The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19 vaccination in children
-
Published:2024-07
Issue:7
Volume:24
Page:666-667
-
ISSN:1473-3099
-
Container-title:The Lancet Infectious Diseases
-
language:en
-
Short-container-title:The Lancet Infectious Diseases
Author:
Li Si-Min,Zhu Feng-Cai
Reference7 articles.
1. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection;Hall;N Engl J Med,2022
2. WHO COVID-19 dashboard,2024
3. Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age;Anderson;N Engl J Med,2022
4. Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age;Creech;N Engl J Med,2022
5. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial;Han;Lancet Infect Dis,2021